Reconceiving Glaucoma Care
Minimizing risk, increasing efficiency, streamlining patient flow and ensuring quality of care during the pandemic—and beyond.
Featured Content
Glaucoma
Which MIGS for Which Patients?
Type of glaucoma, disease severity, patient age, eye size and other factors all may influence your choice.
Dry Eye
Dry Eye: The Blepharitis Connection
How to diagnose and treat blepharitis and why patient education is key.
Cornea
Solving the Puzzle of Corneal Ulcers
How to expect horses—but prepare for zebras—when faced with a corneal infection.
Review of Ophthalmology Online eNewsletter
- Is Reading Performance Impaired in Glaucoma Patients with Preserved Central Vision?
Find out how patients with mild to moderate glaucoma performed on reading performance compared with similarly aged controls. - Risk factors for Fellow Eye Treatment in Protocol T
What factor was said to impact the risk of fellow eye treatment in this post hoc analysis of randomized clinical trial data? - Influence of Posterior Corneal Astigmatism Measurements on Toric IOL Implantation Outcomes
Find out in which eyes posterior corneal astigmatism measurements using AS-OCT improved the outcomes of toric IOL implantation. - Evaluating Treatment Response of Aflibercept in Wet AMD Using OCTA
Was this approach effective in monitoring choroidal neovascular membrane size changes during treatment? - Industry News
Continuing Medical Education
-
A Closer Look: Emerging Medical Therapies for Presbyopia
This CME activity provides an overview of age-related loss of accommodation as well as several of the emerging topical therapies for presbyopia that are under investigation. Perspectives on selection of prospective patients as well as potential opportunities for practice growth are also discussed. -
Don't Miss Neurotrophic Keratitis: New Approaches to Assess and Treat
A panel of experts discuss the importance of early detection of neurotrophic keratitis and the latest data on available treatment options in this CME activity. -
Breaking New Ground: Reducing Treatment Burden in Neovascular AMD
This CME monograph, based on an expert roundtable discussion, will present challenging cases in nAMD along with the latest clinical trial data and perspectives on how the newest advances in nAMD treatment can be translated to the real world.
